CRISPR gene-editing technology is displaying promising potential for the treatment of neurodegenerative diseases, such as Alzheimer’s, Parkinson’s and Huntington’s. Despite neurodegenerative diseases being difficult to treat due to their complexity, early-stage research using CRISPR to edit genes linked to these diseases is proving successful. However, full understanding of these diseases is still lacking, and barriers like effective delivery of treatment and understanding of long-term safety need to be overcome.
UK’s Legal Aid Agency Experiences Cyberattack
A UK Ministry of Justice executive agency was targeted in a cyberattack, compromising its systems. The incident highlights vulnerabilities in cybersecurity, prompting a review of
